|
1
|
Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.
|
Nat Med
|
1996
|
2.73
|
|
2
|
Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase.
|
Leukemia
|
2011
|
2.20
|
|
3
|
Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention.
|
Bone Marrow Transplant
|
2004
|
1.84
|
|
4
|
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
|
J Clin Oncol
|
1993
|
1.07
|
|
5
|
MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature.
|
Pediatr Transplant
|
2010
|
1.03
|
|
6
|
Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2010
|
0.99
|
|
7
|
Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation.
|
Bone Marrow Transplant
|
2007
|
0.97
|
|
8
|
Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS).
|
Bone Marrow Transplant
|
2003
|
0.94
|
|
9
|
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.
|
Bone Marrow Transplant
|
2004
|
0.94
|
|
10
|
Autoimmune disease induced by dendritic cell immunization against leukemia.
|
Leuk Res
|
1999
|
0.94
|
|
11
|
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
|
Leukemia
|
2005
|
0.89
|
|
12
|
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia.
|
Bone Marrow Transplant
|
2007
|
0.85
|
|
13
|
Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I.
|
Klin Padiatr
|
2009
|
0.82
|
|
14
|
Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue.
|
Bone Marrow Transplant
|
1991
|
0.82
|
|
15
|
Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients.
|
J Hosp Infect
|
2005
|
0.82
|
|
16
|
Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
|
Klin Padiatr
|
2004
|
0.81
|
|
17
|
Zinc ions are differentially required for the transcription of ribosomal 5S RNA and tRNA in a HeLa-cell extract.
|
Nucleic Acids Res
|
1984
|
0.81
|
|
18
|
Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells.
|
Bone Marrow Transplant
|
2005
|
0.81
|
|
19
|
High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors.
|
Hum Gene Ther
|
1996
|
0.81
|
|
20
|
Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.
|
J Clin Invest
|
1991
|
0.81
|
|
21
|
Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
|
Klin Padiatr
|
2007
|
0.80
|
|
22
|
Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
|
Klin Padiatr
|
2007
|
0.79
|
|
23
|
Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children.
|
Bone Marrow Transplant
|
2002
|
0.78
|
|
24
|
Trends in infections in children with malignant disease in 2000: comparison of data of 1980/81.
|
Pediatr Hematol Oncol
|
2007
|
0.78
|
|
25
|
Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
|
Exp Hematol
|
1995
|
0.77
|
|
26
|
Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
|
Haematologica
|
2006
|
0.77
|
|
27
|
Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.
|
Eur J Pediatr
|
2015
|
0.77
|
|
28
|
Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
|
Gene Ther
|
2005
|
0.77
|
|
29
|
Increased transduction efficiency of primary hematopoietic cells by physical colocalization of retrovirus and target cells.
|
J Hematother
|
1998
|
0.77
|
|
30
|
Bloodstream infections in paediatric cancer patients. Prospective comparative study in 2 university hospitals.
|
Klin Padiatr
|
2011
|
0.76
|
|
31
|
Favourable long-term outcome after matched sibling transplantation for Fanconi-anemia (FA) and in vivo T-cell depletion.
|
Klin Padiatr
|
2008
|
0.76
|
|
32
|
Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
|
Klin Padiatr
|
2005
|
0.76
|
|
33
|
Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
|
Klin Padiatr
|
2004
|
0.76
|
|
34
|
Measuring gene-transfer efficiency.
|
Nat Med
|
1996
|
0.75
|
|
35
|
[Experimental principles of therapy-oriented pathogenetic classification of aplastic anemia in childhood].
|
Klin Padiatr
|
1994
|
0.75
|
|
36
|
[Immune stimulation with interleukin-2 after autologous stem cell transplantation in children and adolescents with solid tumors].
|
Klin Padiatr
|
1993
|
0.75
|
|
37
|
Tumor vaccines--application to childhood cancer.
|
Klin Padiatr
|
1999
|
0.75
|
|
38
|
Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
|
Klin Padiatr
|
2006
|
0.75
|
|
39
|
Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells.
|
J Cancer Res Clin Oncol
|
2006
|
0.75
|
|
40
|
Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts.
|
Klin Padiatr
|
2008
|
0.75
|
|
41
|
Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD.
|
Klin Padiatr
|
2004
|
0.75
|